Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMI0H3B)

Drug Name	UshStat DMI0H3B
Synonyms	Myosin 7A gene therapy (Usher syndrome 1B, LentiVector), Oxford BioMedica; Myosin VIIA gene therapy (Usher syndrome 1B, LentiVector), Oxford BioMedica

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Phase 1/2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Deafness	DISKCLH4	AB52	Phase 1/2	[1]
------------------------------------------------------------------------------------

1 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Retinitis pigmentosa	DISCGPY8	9B70	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02065011) A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat in Patients With Usher Syndrome Type 1B. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)